Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Journal of Translational Medicine|December 13, 2012
Nimotuzumab promotes radiosensitivity of EGFR-overexpression esophageal squamous cell carcinoma cells by upregulating IGFBP-3Lei Zhao, Li-Ru He, Mian Xi, et al.
Cancer Letters|July 22, 2014
The telomere/telomerase binding factor PinX1 regulates paclitaxel sensitivity depending on spindle assembly checkpoint in human cervical squamous cell carcinomasXiao-Peng Tian, Dong Qian, Li-Ru He, et al.
Gut|August 5, 2011
Overexpression of EIF5A2 promotes colorectal carcinoma cell aggressiveness by upregulating MTA1 through C-myc to induce epithelial-mesenchymaltransitionWei Zhu, Mu-Yan Cai, Zhu-Ting Tong, et al.
Oncotarget|July 30, 2014
Ablation of EIF5A2 induces tumor vasculature remodeling and improves tumor response to chemotherapy via regulation of matrix metalloproteinase 2 expressionFeng-Wei Wang, Mu-Yan Cai, Shi-Juan Mai, et al.
International Journal of Cancer|November 12, 2009
High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapyLi-Ru He, Meng-Zhong Liu, Bin-Kui Li, et al.
Plos One|February 26, 2015
ULK1: a promising biomarker in predicting poor prognosis and therapeutic response in human nasopharygeal carcinomaMiao Yun, Hai-Yan Bai, Jia-Xing Zhang, et al.
Gut|June 16, 2011
The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2Fang Zheng, Yi-Ji Liao, Mu-Yan Cai, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 19, 2015
Overexpression of NKX6.1 is closely associated with progressive features and predicts unfavorable prognosis in human primary hepatocellular carcinomaLin-Lin Huang, Yi Zhang, Jia-Xing Zhang, et al.
Plos Genetics|December 8, 2021
Correction: Systemic Delivery of MicroRNA-101 Potently Inhibits Hepatocellular Carcinoma In Vivo by Repressing Multiple TargetsFang Zheng, Yi-Ji Liao, Mu-Yan Cai, et al.
Plos Genetics|February 19, 2015
Systemic delivery of microRNA-101 potently inhibits hepatocellular carcinoma in vivo by repressing multiple targetsFang Zheng, Yi-Ji Liao, Mu-Yan Cai, et al.
Pageof 5